Alnylam Pharmaceuticals, Inc. (ALNY)

392.10 +0.93 (+0.24%) USD  |  NASDAQ  |  Dec 17, 16:00
392.17 +0.07 (+0.02%) After-Hours: 20:00
More

Alnylam Pharmaceuticals EV to EBITDA (Forward)

EV to EBITDA (Forward) Chart

View EV to EBITDA (Forward) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to EBITDA (Forward) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Forward EV / EBITDA Definition

View Forward EV / EBITDA Definition
Start Trial

Forward EV / EBITDA shows how many dollars of enterprise value a company is worth per dollar of estimated EBITDA at the end of the current fiscal year.

Read full definition.

EV to EBITDA (Forward) Range, Past 5 Years

View EV to EBITDA (Forward) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to EBITDA (Forward) Benchmarks

View EV to EBITDA (Forward) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade
Amgen, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade